In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Valeant pays $312mm for OraPharma plus potential $114mm in earn-outs

Executive Summary

Keeping up its string of acquisitions, Valeant Pharmaceuticals International Inc. is buying closely held oral health company OraPharma Inc. from private equity firm Water Street Healthcare Partners for $312mm in cash up front and up to $114mm in earn-outs based on milestones including revenue targets.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register